CLINICAL_TRIALS
trial_result
· 2013-12-13
Clinical Trial Update: Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder [Phase 3]
Summary
Phase 3 clinical trial results show efficacy and safety data for vortioxetine in adults with major depressive disorder (Takeda-sponsored; completed with results…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2013-12-13